U.S., May 1 -- ClinicalTrials.gov registry received information related to the study (NCT06950398) titled 'Normothermic Oxygenated Perfusion (NMP) Viability Testing Before Transplantation of Discarded Livers' on Nov. 19, 2024.
Brief Summary: Liver transplantation (LT) is a highly effective treatment for end-stage liver disease and early-stage primary liver cancer. As such, the demand for donor livers greatly exceeds supply; in 2021 in France, 12.9% of patients on the waitlist either died or were delisted for worsening of their condition.
However a substantial number of perfectly viable organs are wrongly discarded based on a highly subjective assessment as the level of acceptance varies widely depending on the physician's judgement.
The ...